202 related articles for article (PubMed ID: 15843786)
1. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project--six sites, United States, January 1-June 15, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(15):380-3. PubMed ID: 15843786
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
Jhung MA; Budnitz DS; Mendelsohn AB; Weidenbach KN; Nelson TD; Pollock DA
Med Care; 2007 Oct; 45(10 Supl 2):S96-102. PubMed ID: 17909391
[TBL] [Abstract][Full Text] [Related]
3. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.
Hougland P; Xu W; Pickard S; Masheter C; Williams SD
Med Care; 2006 Jul; 44(7):629-36. PubMed ID: 16799357
[TBL] [Abstract][Full Text] [Related]
4. Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system.
Budnitz DS; Pollock DA; Mendelsohn AB; Weidenbach KN; McDonald AK; Annest JL
Ann Emerg Med; 2005 Feb; 45(2):197-206. PubMed ID: 15671977
[TBL] [Abstract][Full Text] [Related]
5. National estimates of nonfatal injuries treated in hospital emergency departments--United States, 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 May; 50(17):340-6. PubMed ID: 11465904
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
Wysowski DK; Swartz L
Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
[TBL] [Abstract][Full Text] [Related]
7. Nonfatal self-inflicted injuries treated in hospital emergency departments--United States, 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 May; 51(20):436-8. PubMed ID: 12056500
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
Al-Tajir GK; Kelly WN
Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug event reporting in intensive care units: a survey of current practices.
Kane-Gill SL; Devlin JW
Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
[TBL] [Abstract][Full Text] [Related]
10. Nonfatal physical assault-related injuries treated in hospital emergency departments--United States, 2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 May; 51(21):460-3. PubMed ID: 12054424
[TBL] [Abstract][Full Text] [Related]
11. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System.
Ross MP; Ferguson M; Street D; Klontz K; Schroeder T; Luccioli S
J Allergy Clin Immunol; 2008 Jan; 121(1):166-71. PubMed ID: 18206508
[TBL] [Abstract][Full Text] [Related]
12. Early detection of adverse drug events within population-based health networks: application of sequential testing methods.
Brown JS; Kulldorff M; Chan KA; Davis RL; Graham D; Pettus PT; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1275-84. PubMed ID: 17955500
[TBL] [Abstract][Full Text] [Related]
13. A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.
Sullivan JW
Am J Hosp Pharm; 1990 Jun; 47(6):1342-5. PubMed ID: 2368728
[TBL] [Abstract][Full Text] [Related]
14. Medication safety program reduces adverse drug events in a community hospital.
Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
[TBL] [Abstract][Full Text] [Related]
15. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
[TBL] [Abstract][Full Text] [Related]
16. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
[TBL] [Abstract][Full Text] [Related]
17. Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data.
Nebeker JR; Yarnold PR; Soltysik RC; Sauer BC; Sims SA; Samore MH; Rupper RW; Swanson KM; Savitz LA; Shinogle J; Xu W
Med Care; 2007 Oct; 45(10 Supl 2):S81-8. PubMed ID: 17909388
[TBL] [Abstract][Full Text] [Related]
18. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
Cohen AL; Budnitz DS; Weidenbach KN; Jernigan DB; Schroeder TJ; Shehab N; Pollock DA
J Pediatr; 2008 Mar; 152(3):416-21. PubMed ID: 18280852
[TBL] [Abstract][Full Text] [Related]
19. Public health and aging: nonfatal physical assault-related injuries among persons aged >60 years treated in hospital emergency departments--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Aug; 52(34):812-6. PubMed ID: 12944878
[TBL] [Abstract][Full Text] [Related]
20. The role of databases in drug postmarketing surveillance.
Rodriguez EM; Staffa JA; Graham DJ
Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
